original ) (raw )Receptor-mediated uterine effects of vasopressin and oxytocin in nonpregnant women
Tadeusz Laudanski
BJOG: An International Journal of Obstetrics and Gynaecology, 1995
View PDFchevron_right
Interaction of vasopressin and prostaglandins in the nonpregnant human uterus
Ana Kostrzewska , Tadeusz Laudanski
Prostaglandins, 1984
View PDFchevron_right
Endometrial Na+, K+-ATPase pump function and vasopressin levels during hysteroscopic surgery in patients pretreated with GnRH agonist
Feza Burak
The Journal of the American Association of Gynecologic Laparoscopists, 1998
View PDFchevron_right
Plasma arginine vasopressin response to water load during labor
Sunit Singhi
International Journal of Gynecology & Obstetrics, 1985
View PDFchevron_right
Differences in the effects of vasopressin and oxytocin on rabbit myometrial activity and a possible mediation of prostaglandins
Satish Batra
Reproduction, 1977
View PDFchevron_right
Interaction of Vasopressin and Prostaglandin on Myometrial Activity in Vivo in the First Trimester of Human Pregnancy
Tadeusz Laudanski
BJOG: An International Journal of Obstetrics and Gynaecology, 1980
View PDFchevron_right
Osmotically-induced release of vasopressin and oxytocin in non-pregnant women - influence of estrogen and progesterone
Thomas Bossmar
Acta Obstetricia et Gynecologica Scandinavica, 1998
View PDFchevron_right
Effect of the non-peptide, vasopressin V1a receptor antagonist, SR 49059 and its enantiomer, SR 49770, on isolated human myometrium
Thomas Bossmar
2009
View PDFchevron_right
The effect of intracervical vasopressin on the systemic absorption of glycine during hysteroscopic endometrial ablation
D. Bider
Obstetrics & Gynecology, 1996
View PDFchevron_right
Myometrial response to a long-acting vasopressin analogue in early pregnancy
Tadeusz Laudanski
British Journal of Obstetrics and Gynaecology
View PDFchevron_right
Responses to a Saline Load in Gonadotropin-Releasing Hormone Antagonist-Pretreated Premenopausal Women Receiving Progesterone or Estradiol-Progesterone Therapy
David Keefe
The Journal of Clinical Endocrinology & Metabolism, 2005
View PDFchevron_right
Labelling of vasopressin and oxytocin receptors from the human uterus
Gilles Guillon
European Journal of Pharmacology, 1990
View PDFchevron_right
A Study of the Effect of Vasopressin in Reducing Blood Loss in Gynaecological Surgeries
RAKHI KUMARI
GLOBAL JOURNAL FOR RESEARCH ANALYSIS, 2021
View PDFchevron_right
Effects of arginine- and lysine-vasopressin on phospholipase C activity, intracellular calcium concentration and prostaglandin F2alpha secretion in pig endometrial cells
mark mirando
Reproduction, 2001
View PDFchevron_right
The development of an arginine vasopressin rodent model for the study of preeclampsia
Sanil Singh
Placenta, 2019
View PDFchevron_right
Characterization of arginine vasopressin actions in human uterine artery: lack of role of the vascular endothelium
Ivan Tulic
British Journal of Pharmacology, 1995
View PDFchevron_right
Effect of SR49059, an orally active V1a vasopressin receptor antagonist, in the prevention of dysmenorrhoea
Thomas Bossmar
BJOG: An International Journal of Obstetrics and Gynaecology, 2000
View PDFchevron_right
Effects of SR 49059, an orally active V1a vasopressin receptor antagonist, on vasopressin-induced uterine contractions
Thomas Bossmar
BJOG: An International Journal of Obstetrics and Gynaecology, 1997
View PDFchevron_right
A comparative study between the efficacy of local intra-myometrial injection of vasopressin and octreotide acetate, in reducing blood loss during myomectomy
laila mohamed
View PDFchevron_right
Normal Saline and Dextrose-Saline Infusion Comparison in the Duration of Active Phase in Nulliparous Women
hamideh pakniat
Biotechnology and Health Sciences, 2015
View PDFchevron_right
Osmoregulation, the secretion of arginine vasopressin and its metabolism during pregnancy
John Davison
European Journal of Endocrinology, 1995
View PDFchevron_right
Relaxant effect of oxytocin on isolated human oviduct
Mirjana Varjacic
Croatian medical journal, 2001
View PDFchevron_right
Is Vasopressin Involved as a Local Mediator in the Mechanism of Parturition?
Carlo Ticconi
Annals of the New York Academy of Sciences, 1994
View PDFchevron_right
Intramyometrial vasopressin as a haemostatic agent during myomectomy
Horace Fletcher
BJOG: An International Journal of Obstetrics and Gynaecology, 1994
View PDFchevron_right
Dose-response effects of pressor doses of arginine vasopressin on renal haemodynamics in the rat
Andrew McVicar
The Journal of Physiology, 1988
View PDFchevron_right
Receptor binding of oxytocin and vasopressin antagonists and inhibitory effects on isolated myometrium from preterm and term pregnant women
Ana Kostrzewska , Tadeusz Laudanski
BJOG: An International Journal of Obstetrics and Gynaecology, 1999
View PDFchevron_right
Vasopressors and tight control of maternal blood pressure during cesarean delivery: A rocky alliance
Sunanda Gupta
Journal of Anaesthesiology Clinical Pharmacology, 2013
View PDFchevron_right
Comparison of Oxytocin 3IU Bolus + I.V. Infusion 0f 30IU at the Rate of 125 ml/Hr.(0.125 IU/Min.) and oxytocin I.V. infusion at 0.125 IU/Min only, in maintaining uterine tone and hemodynamic stability
Dr. K T Venkatesh Murthy
Indian Journal of Clinical Anaesthesia, 2021
View PDFchevron_right
Role of Vasopressin Injection Intramyometrial in Decreasing Blood Loss During Abdominal Myomectomy (A Randomized Controlled Trial)
Amro Elhoussieny
Evidence Based Womenʼs Health Journal, 2020
View PDFchevron_right
Vasoactive intestinal polypeptide (VIP) increases vaginal blood flow and inhibits uterine smooth muscle activity in women
Bent Ottesen
European Journal of Clinical Investigation, 1983
View PDFchevron_right
Role of the endogenous opioid system in the analgesic effect of ?-tocopherol in dysmenorrhea
Konstantin N Yarygin
Bulletin of Experimental Biology and Medicine, 1988
View PDFchevron_right